Health Trials

Phase 2 Efficacy Study of Sildenafil Products in Adult Men With Erectile Dysfunction

ConditionErectile Dysfunction
Trial statusNot yet recruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexMale
Age18-70
SponsorAspargo Labs, Inc

About this trial

The goal of this clinical trial is to learn how different sildenafil-based erectile dysfunction (ED) treatments affect erectile function in adult men. The main questions it aims to answer are:

Does each assigned product improve erectile function over 12 weeks?

What safety or tolerability issues occur when these products are used on an on-demand basis?

Researchers will compare Hezkue® and Hezkue Turbo® with several commercially available sildenafil or sildenafil-plus-tadalafil products to see whether there are differences in effectiveness, treatment experience, or safety.

Participants will:

* Use one assigned ED treatment on demand for 12 weeks * Complete electronic diaries and questionnaires about sexual-encounter outcomes and treatment satisfaction * Attend study visits for safety checks, laboratory tests, and assessments of erectile function

Eligibility criteria

Qualifiers

Male, 18 to 70 years of age.

Disqualifiers

Use of nitrates or nitric oxide donors in any form.

Trial design

Treatments tested in this trial

  • Hezkue
  • Hezkue Turbo
  • Galotam
  • BlueChew
  • Pfizer Viagra
  • Aristo Sildaristo
  • Lemonaid Health Sildenafil
  • Ro Sparks
  • Hims Hard Mints
  • Hello Cake ED Cake Meds

Treatment groups

200 Participants
are divided into 10 treatment groups

10

Treatment groups

See each treatment group below.

Locations

This trial has no locations

Sponsors and collaborators

Aspargo Labs, Inc

Lead sponsor

Source ClinicalTrials.gov